Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect of Dalfampridine on Gait Incoordination in Spinocerebellar Ataxias- A Randomized, Double-blinded, Placebo-controlled, Crossover Clinical Trial

NCT01811706 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT01811706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01811706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect of Dalfampridine on Gait Incoordination in Spinocerebellar Ataxias- A Randomized, Double-blinded, Placebo-controlled, Crossover Clinical Trial
Lead sponsor
University of Florida
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2013
Completion date
December 31, 2013
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinocerebellar ataxias type 1, spinocerebellar ataxias type 2, spinocerebellar ataxias type 3, spinocerebellar ataxias type 6